November 2017 FDA Recall Nexterone by Baxter Healthcare Corporation
D-0573-2018 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Baxter Healthcare Corporation on November 10, 2017 for the product Nexterone. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0573-2018

Reason for Recall
Presence of Particulate Matter:Particulate identified as polyethylene, the primary constituent of the film and ports used to manufacture the bag in which product is packaged
Initiated
11-10-2017
Reported
02-07-2018
Quantity
35,628 single-dose containers

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Baxter Healthcare Corporation
Nationwide within USA and Puerto Rico
Nexterone (amiodarone HCl) Premixed Injection, 150mg/100mL, 100-mL bag, Rx Only, Sterile, Baxter Healthcare Corporation, Deerfield, IL. NDC 43066-150-10

Batch or Lot Expiration Information

Lot# Expiry: NC109925, Exp 6/1/2019; NC109123, 5/2019

Affected Packages Involved in this Recall